Cargando…
(223)Ra-dichloride therapy of bone metastasis: optimization of SPECT images for quantification
BACKGROUND: (223)Ra imaging is crucial to evaluate the successfulness of the therapy of bone metastasis of castration-resistant prostate cancer (CRPC). The goals of this study were to establish a quantitative tomographic (223)Ra imaging protocol with clinically achievable conditions, as well as to i...
Autores principales: | Benabdallah, Nadia, Bernardini, Michela, Bianciardi, Marta, de Labriolle-Vaylet, Claire, Franck, Didier, Desbrée, Aurélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384291/ https://www.ncbi.nlm.nih.gov/pubmed/30790144 http://dx.doi.org/10.1186/s13550-019-0488-7 |
Ejemplares similares
-
Response to (223)Ra-dichloride in castration-resistant prostate cancer with bone metastasis: A case report
por: Cabrera, Montserrat Estorch, et al.
Publicado: (2016) -
Ultrastructural Analysis of Cancer Cells Treated with the Radiopharmaceutical Radium Dichloride ([(223)Ra]RaCl(2)): Understanding the Effect on Cell Structure
por: Diniz Filho, Joel Félix Silva, et al.
Publicado: (2023) -
Radium 223 dichloride for prostate cancer treatment
por: Deshayes, Emmanuel, et al.
Publicado: (2017) -
(223)Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice
por: Dizdarevic, Sabina, et al.
Publicado: (2018) -
Chemotherapy following radium‐223 dichloride treatment in ALSYMPCA
por: Sartor, Oliver, et al.
Publicado: (2016)